Clinical Actionability of the Genomic Landscape of Metastatic Castration Resistant Prostate Cancer

被引：13
|
作者：
Devlies, Wout [1 ,2 ]
Eckstein, Markus [3 ]
Cimadamore, Alessia [4 ]
Devos, Gaetan [1 ]
Moris, Lisa [1 ,2 ]
van den Broeck, Thomas [1 ]
Montironi, Rodolfo [4 ]
Joniau, Steven [1 ]
Claessens, Frank [2 ]
Gevaert, Thomas [5 ]
机构：
[1] Univ Hosp Leuven, Dept Urol, B-3000 Leuven, Belgium
[2] Katholieke Univ Leuven, Lab Mol Endocrinol, B-3000 Leuven, Belgium
[3] Friedrich Alexander Univ Erlangen Nurnberg, Dept Pathol, D-91054 Erlangen, Germany
[4] Polytech Univ theMarche Reg, United Hosp, Sch Med, Sect Pathol Anat, I-60121 Ancona, Italy
[5] Univ Hosp Leuven, Dept Pathol, B-3000 Leuven, Belgium
来源：
CELLS | 2020年 / 9卷 / 11期
关键词：
prostate cancer; biomarker; targeted therapies; histology; mCRPC; androgen receptor; ANDROGEN-DEPRIVATION THERAPY; CIRCULATING TUMOR-CELLS; POZ PROTEIN SPOP; EMERGING MECHANISMS; RECEPTOR; EXPRESSION; MUTATIONS; GENE; TMPRSS2-ERG; INHIBITORS;
D O I：
10.3390/cells9112494
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
The development of targeted therapies increases treatment options for metastatic castration resistant prostate cancer (mCRPC) patients. There is a need for strong predictive and prognostic signatures to guide physicians in treating mCRPC patients. In this review we unravel the possible actionability in the AR pathway, PI3K AKT signaling, and DNA repair pathways. Additionally, we make recommendations on biomarker trial design, and the clinical use of this new type of data.
引用
收藏
页码：1 / 13
页数：13
相关论文
共 50 条
  • [1] Genomic landscape of older versus younger men with metastatic castration-resistant prostate cancer
    Knox, Andrea
    Fettke, Heide
    Hauser, Christine
    Bukczynska, Patricia
    Ng, Nicole
    Foroughi, Siavash
    Graham, Lisa-Jane
    Mahon, Kate
    Tan, Winston
    Zheng, Tiantian
    Yu, Jianjun
    Dai, Chao
    Du, Pan
    Jia, Shidong
    Horvarth, Lisa
    Kohli, Manish
    Azad, Arun
    Kwan, Edmond
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 : 54 - 55
  • [2] The changing landscape in metastatic castration-resistant prostate cancer
    Leibowitz-Amit, Raya
    Joshua, Anthony M.
    CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2013, 7 (03) : 243 - 248
  • [3] The changing landscape in the treatment of metastatic castration-resistant prostate cancer
    El-Amm, Joelle
    Aragon-Ching, Jeanny B.
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2013, 5 (01) : 25 - 40
  • [4] Metastatic castration-resistant prostate cancer: changing landscape with cabazitaxel
    Fernandez, Ovidio
    Afonso, Javier
    Vazquez, Sergio
    Campos, Begona
    Lazaro, Matin
    Leon, Luis
    Anton Aparicio, Luis M.
    ANTI-CANCER DRUGS, 2014, 25 (03) : 237 - 243
  • [5] Clinical and genomic characterization of Low PSA Secretors: a unique subset of metastatic castration resistant prostate cancer
    Aggarwal, Rahul
    Romero, Gustavo Rubio
    Friedl, Verena
    Weinstein, Alana
    Foye, Adam
    Huang Jiaoti
    Feng, Felix
    Stuart, Joshua M.
    Small, Eric J.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2021, 24 (01) : 81 - 87
  • [6] Clinical and genomic characterization of Low PSA Secretors: a unique subset of metastatic castration resistant prostate cancer
    Rahul Aggarwal
    Gustavo Rubio Romero
    Verena Friedl
    Alana Weinstein
    Adam Foye
    Jiaoti Huang
    Felix Feng
    Joshua M. Stuart
    Eric J. Small
    Prostate Cancer and Prostatic Diseases, 2021, 24 : 81 - 87
  • [7] Clinical and genomic hallmarks of low PSA secretors in metastatic castration-resistant prostate cancer (mCRPC).
    Romero, Gustavo Rubio
    Weinstein, Alana
    Friedl, Verena
    Foye, Adam
    Playdle, Denise
    Sabol, Alexis
    Li, Patricia
    Huang, Jiaoti
    Feng, Felix Y.
    Stuart, Joshua M.
    Small, Eric Jay
    Aggarwal, Rahul Raj
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [8] The genomic landscape of metastatic castration-resistant prostate cancers reveals multiple distinct genotypes with potential clinical impact
    van Dessel, Lisanne F.
    van Riet, Job
    Smits, Minke
    Zhu, Yanyun
    Hamberg, Paul
    van der Heijden, Michiel S.
    Bergman, Andries M.
    van Oort, Inge M.
    de Wit, Ronald
    Voest, Emile E.
    Steeghs, Neeltje
    Yamaguchi, Takafumi N.
    Livingstone, Julie
    Boutros, Paul C.
    Martens, John W. M.
    Sleijfer, Stefan
    Cuppen, Edwin
    Zwart, Wilbert
    van de Werken, Harmen J. G.
    Mehra, Niven
    Lolkema, Martijn P.
    NATURE COMMUNICATIONS, 2019, 10 (1)
  • [9] The genomic landscape of metastatic castration-resistant prostate cancers reveals multiple distinct genotypes with potential clinical impact
    Lisanne F. van Dessel
    Job van Riet
    Minke Smits
    Yanyun Zhu
    Paul Hamberg
    Michiel S. van der Heijden
    Andries M. Bergman
    Inge M. van Oort
    Ronald de Wit
    Emile E. Voest
    Neeltje Steeghs
    Takafumi N. Yamaguchi
    Julie Livingstone
    Paul C. Boutros
    John W. M. Martens
    Stefan Sleijfer
    Edwin Cuppen
    Wilbert Zwart
    Harmen J. G. van de Werken
    Niven Mehra
    Martijn P. Lolkema
    Nature Communications, 10
  • [10] Metastatic castration-resistant prostate cancer
    Henriques, Vanessa
    Wenzel, Mike
    Demes, Melanie-Christin
    Koellermann, Jens
    PATHOLOGE, 2021, 42 (04): : 431 - 438
12345